minor innovations, procurement of patented medicines by government for public distribution, encouraging healthcare insurance, fostering Industry-Institute partnerships etc. may help balance access to affordable…
above the poverty line. The study recommended the need for expansion of social health insurance through the National Health Insurance Scheme to cover the informal sector as a means
study investigated closed claims concerned with medical-related deaths registered by the Danish Patient Insurance Association (DPIA). The present study used data from all reported complications from medical treatment
records, and longitudinal follow-up. Population studies of SLE are often performed based on insurance and hospitalization records. A better understanding of the significance of hospitalization frequency could enhance
adult patients were from the General Out Patients Department (GOPD) and National Health Insurance Scheme (NHIS) section of the hospital in Eastern Nigeria
Union standards and adapts the Bologna system. One of the main concerns of health insurance scheme in Albania has continuously been the care for patients suffering from cancer disease. Some
social barriers that prevent pharmacists from being recognized as legitimate vaccine administrators, d) some insurance carriers still don’t pay for pharmacist-administered vaccinations, e) CCCs may not currently
focusing on preventative measures and lifestyle modifications initiated from the worksite. The Employee State Insurance Corporation (ESIC) is government operated and the largest health insurance company in India and…
bound to do in dealing with the patient; and the charter of patients’ rights insures the improvement of relationship between the patient and medical personnel. This study is a challenge
data was also collected. The selected factors are demographic (age, race, marital status), structural (insurance coverage) and behavioral (screening history). No significant relationships were found for the factors and…
workplace & surrounding communities, and would bring down future operating costs in many ways from insurance premiums to O&M costs. Thus this white paper summarizes some of the best means
allograft dysfunction early after kidney transplantation are not well-described. Methods: Data for Medicare-insured adult kidney transplant recipients in 1995-2004 who did not develop permanent graft failure
obstetric or non-obstetric and compared for differences in maternal race, age and insurance provider. Results: 576,846 total maternal admissions were identified with 35,158 antepartum
antidiabetics were reduced nearly 3 already in the 6th month after the surgery. Insurance companies currently do not take in consideration different costs for the partial surgery methods
This paper describes the complex Greek health insurance system in 2011 and how it funds some aspects of oral health care for the population. It explains how different aspects ... oral health care for different groups in…
society for organ donation, security financial resources and government support and individuals charitable and insurance institutions and the lack of precise knowledge topics transplant especially brain death on behalf
have suboptimal health (47% vs. 14%), suboptimal dental condition (65% vs. 31%), no health insurance (32% vs. 7%), nopersonal doctor or nurse (42% vs. 15%), problems obtaining specialty care
community interventions (e.g. providing schemes for partial funding community payment or pre-payment schemes, insurance programmes, private or social insurance, through subsidies). The government should also prioritise…
components was depicted using MATLAB and Edraw Max 5 softwares. Results: Capitation, third party insurance, insurance for non-traffics cases, the budget of some especial organizations such as the tobacco ... population…
being at the fountain-head of wealth as well as the best form of insurance against domination by other ethnic or social groups, ethnic groups (and by implication, political parties
Patients today are seeking better health care, while healthcare providers and insurance companies are calling for cost-effective diagnosis and treatments. The biomedical industry thus faces the challenge of developing